We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




In Vitro Technique Details Cancer Cell Attachment and Spread

By LabMedica International staff writers
Posted on 02 Oct 2018
A team of Japanese cell biologists described the development of a simple live-tumor in vitro imaging technique that enabled the study of the processes involved in the growth and spread of pancreatic cancer.

Investigators at Hokkaido University (Japan) reported in the September 19, 2018, online edition of the journal Scientific Reports that they had invented a new cell culture substrate comprising a coated nanoscale glass slide with etched islands of 30 micrometers in diameter, which allowed dynamic visualization of pancreatic ductal adenocarcinoma (PDAC) microtumors.

The investigators reported that when PDAC cells were cultured on the etched slides overnight, the cells self-organized into non-spheroidal microtumors that were anchored to the surface through cell-in-cell invasion (entosis). More...
Using a time-lapse imaging system, they found that PDAC microtumors actively stretched to catch dead cell debris via filipodia (hair-like projections similar to those used for locomotion by some amoebas) and lamellipodia (cytoskeletal actin projections on the mobile edge of the cell).

The etched microplate method enabled visualization of live tumor dynamics; the microtumors endocytosed debris-derived surface nucleosides directly into vacuoles and then accumulated dead cell-derived phosphatidylserine (PS) on their surfaces (resulting in PS externalization, a cause of cancer immune evasion).

"Cancer studies so far either use cell cultures in which cancer cells do not necessarily behave naturally, or tissue samples that do not allow live observation. So there is a big gap in our knowledge of how cancer cells actually behave," said first author Dr. Yukiko Miyatake, assistant professor of pathology at Hokkaido University. "I hope this easy and low-cost technique will find widespread adoption. If the discoveries made during these first observations are physiologically or pathologically relevant phenomena, many more new hints may be gleaned for the development of more effective cancer treatment approaches."

Related Links:
Hokkaido University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.